Detection of novel genetic markers of susceptibility to preeclampsia based on an analysis of the regulatory genes in the placental tissue
- Authors: Serebrova V.N.1, Trifonova E.A.1,2, Gabidulina T.V.3, Bukharina I.Y.3, Agarkova T.A.3, Evtushenko I.D.4, Maksimova N.R.5, Stepanov V.A.1,2
-
Affiliations:
- Research Institute of Medical Genetics
- National Research Tomsk State University
- The Institute for Obstetrics and Gynecology
- Regional Perinatal Center
- Laboratory of Genome Medicine, Clinics of Medical Institute
- Issue: Vol 50, No 5 (2016)
- Pages: 768-776
- Section: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/162839
- DOI: https://doi.org/10.1134/S0026893316050162
- ID: 162839
Cite item
Abstract
Regulatory single nucleotide polymorphisms (rSNPs) are the least-studied group of SNP; however, they play an essential role in the development of human pathology by altering the level of candidate genes expression. In this work, we analyzed 29 rSNPs in 17 new candidate genes associated with preeclampsia (PE) according to the analysis of the transcriptome in placental tissue. Three ethnic groups have been studied (Yakut, Russian, and Buryat). We have detected significant associations of PE with eight rSNPs in six differentially expressed genes, i.e., rs10423795 in the LHB gene; rs3771787 in the HK2 gene; rs72959687 in the INHA gene; rs12678229, rs2227262, and rs3802252 in the NDRG1 gene; rs34845949 in the SASH1 gene; and rs66707428 in the PPP1R12C gene. We used a new approach to detecting genetic markers of multifactorial diseases in the case of PE based on a combination of genomic, transcriptomic, and bioinformatic approaches. This approach proved its efficiency and may be applied to detecting new potential genetic markers in genes involved in disease pathogenesis, which reduces missing heritability in multifactorial diseases.
About the authors
V. N. Serebrova
Research Institute of Medical Genetics
Author for correspondence.
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634050
E. A. Trifonova
Research Institute of Medical Genetics; National Research Tomsk State University
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
T. V. Gabidulina
The Institute for Obstetrics and Gynecology
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634063
I. Yu. Bukharina
The Institute for Obstetrics and Gynecology
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634063
T. A. Agarkova
The Institute for Obstetrics and Gynecology
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634063
I. D. Evtushenko
Regional Perinatal Center
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634063
N. R. Maksimova
Laboratory of Genome Medicine, Clinics of Medical Institute
Email: vika.serebrova@medgenetics.ru
Russian Federation, Yakutsk, 677019
V. A. Stepanov
Research Institute of Medical Genetics; National Research Tomsk State University
Email: vika.serebrova@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
Supplementary files
